000 01240 a2200349 4500
005 20250516125354.0
264 0 _c20130627
008 201306s 0 0 eng d
022 _a1465-993X
024 7 _a10.1186/1465-9921-13-117
_2doi
040 _aNLM
_beng
_cNLM
100 1 _avan de Kant, Kim D G
245 0 0 _aClinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review.
_h[electronic resource]
260 _bRespiratory research
_cDec 2012
300 _a117 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis; Review; Systematic Review
650 0 4 _aBiomarkers
_xanalysis
650 0 4 _aBreath Tests
_xmethods
650 0 4 _aExhalation
650 0 4 _aHumans
650 0 4 _aLung Diseases
_xdiagnosis
650 0 4 _aPrevalence
650 0 4 _aReproducibility of Results
650 0 4 _aSensitivity and Specificity
650 0 4 _aVolatile Organic Compounds
_xanalysis
700 1 _avan der Sande, Linda J T M
700 1 _aJöbsis, Quirijn
700 1 _avan Schayck, Onno C P
700 1 _aDompeling, Edward
773 0 _tRespiratory research
_gvol. 13
_gp. 117
856 4 0 _uhttps://doi.org/10.1186/1465-9921-13-117
_zAvailable from publisher's website
999 _c22364593
_d22364593